Haobin Li

Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer

Jinyun Dong, Xuefei Yu, Jiangjiang Qin, 2022, Frontiers in Pharmacology.

Therapeutic targeting of glutamate dehydrogenase 1 that links metabolic reprogramming and Snail-mediated epithelial-mesenchymal transition in drug-resistant lung cancer.

Guangji Wang, Jun Wang, Minjie Sun, 2022, Pharmacological research.

Protein degradation technology: a strategic paradigm shift in drug discovery

Jinyun Dong, Xiang-dong Cheng, Zhiyuan Xu, 2021, Journal of Hematology & Oncology.

S3I-201 derivative incorporating naphthoquinone unit as effective STAT3 inhibitors: Design, synthesis and anti-gastric cancer evaluation.

Jinyun Dong, Chu Chu, Jiangjiang Qin, 2022, Bioorganic & medicinal chemistry.

Discovery of benzochalcone derivative as a potential antigastric cancer agent targeting signal transducer and activator of transcription 3 (STAT3)

Yun Shi, Jinyun Dong, Jing Yang, 2022, Journal of enzyme inhibition and medicinal chemistry.

Therapeutic targeting of glutamate dehydrogenase 1 that links metabolic reprogramming and Snail-mediated epithelial-mesenchymal transition in drug-resistant lung cancer.

Guangji Wang, Jun Wang, Minjie Sun, 2022, Pharmacological research.

Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4.

Jinyun Dong, Yulong Li, Furong Ma, 2023, Bioorganic & medicinal chemistry.